News + Font Resize -

Tecan ties up with Miltenyi Biotec to develop automated solutions for cell biology
Switzerland | Wednesday, August 18, 2010, 08:00 Hrs  [IST]

Tecan is working with Miltenyi Biotec, a leading provider of cell biology solutions, to develop a range of automated solutions for cell biology, based on the powerful MACS Magnetic bead technology. This new agreement will allow customers to benefit from the advanced capabilities of Tecan's Freedom EVO liquid handling platforms when performing a wide range of separation, cultivation and analysis processes for cells and biomolecules.

Tecan will be supporting full integration of the MultiMACS Separator family of biomolecular and cellular separation devices onto the deck of the instrument, as well as providing software solutions for straightforward incorporation of complete Miltenyi Biotec systems, including the autoMACS Pro Separator, the gentleMACS Dissociator and the MACSQuant Analyzer. "We are extremely pleased to be working together with Miltenyi Biotec to provide valuable automated solutions to our customers in this fast growing area of cell biology," commented Christoph Kaufmann, Tecan's Head of Product Management and Marketing.

"Miltenyi Biotec's expertise in cellular biology and the flexible range of high quality products will now come with the added advantages of automation, ensuring that our customers will benefit from an unrivalled portfolio of solutions for processing and analysis of cells and biomolecules," added Uwe Janssen, Business Development at Miltenyi Biotec.

Tecan is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories.

Miltenyi Biotec's company mission is to improve scientific understanding and medical progress by providing products and services for cellular therapies. With approx. 1100 employees in 18 countries, Miltenyi Biotec develops, manufactures, and commercializes innovations for both research and clinical applications.

Post Your Comment

 

Enquiry Form